Bridging Europe’s Biomanufacturing Gaps

The European Medical Biotech sector is strategic but faces significant barriers, particularly in emerging ecosystems like Campania and Silesia. BRIDGE directly addresses:
Gap: Lack of specialised talent in bioprocessing and advanced manufacturing.
Ecosystem Fragmentation: Weak links between academia, R&D, and industry
Funding Access: Limited access to targeted venture capital and appropriate scale-up infrastructure
